• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

己酮可可碱对缺血性心脏病中PAG1/miR-1206/SNHG14基因表达的影响

Influence of pentoxifylline on gene expression of PAG1/ miR-1206/ SNHG14 in ischemic heart disease.

作者信息

Abd El-Aziz Ahlam, El-Desouky Mohamed Ali, Shafei Ayman, Elnakib Mostafa, Abdelmoniem Amr Mohamed

机构信息

Department of Chemistry, Biochemistry Division, Faculty of Science, Cairo University, Egypt.

Military Medical Academy, Faculty of Medicine, Modern University for Technology and Information, Cairo, Egypt.

出版信息

Biochem Biophys Rep. 2021 Jan 27;25:100911. doi: 10.1016/j.bbrep.2021.100911. eCollection 2021 Mar.

DOI:10.1016/j.bbrep.2021.100911
PMID:33553684
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7846894/
Abstract

The regulation by immune checkpoint is able to prevent excessive tissue damage caused by ischemia reperfusion (I/R); therefore, the study aims to investigate the behavior of phosphoprotein associated with glycosphingolipid-enriched microdomains 1 (PAG1) mRNA, miR-1206 and small nucleolar RNA host gene 14 (SNHG14) during I/R and intake of pentoxifylline (PTX) as a protective drug. The relative expression level of PAG1/miR-1206/SNHG14 was determined by qRT-PCR. Cardiac tissue levels of cytotoxic T-lymphocyte associated antigen 4 (CTLA4) and PAG1 protein expression were determined by ELISA technique. The regulatory T cells achieved by the flow cytometry. The results found that the relative expression of SNHG14 was significantly upregulated in I/R, but suppressed in PTX treated groups with enhancement of the relative expression level of miR-1206. The gene and protein expression of PAG1 were downregulated with effective doses of PTX. The results showed that (30 and 40 mg/kg bwt) PTX dose suppressed the CTLA4 development significantly. The mean of the regulatory T cell in PTX protective groups is significantly reduced at (p < 0.001) in a comparison with I/R group. Spearman's correlation analysis revealed a significant negative correlation between SNHG14 and miR-1206, but a significant positive correlation between SNHG14 and PAG1 in I/R heart tissue. The results indicated that miR-1206 and SNHG14 can be used as biomarkers with perfect sensitivity and specificity. Using PTX reduced cardiac tissue damage. SNHG14 and miR-1206 can be used as a diagnostic tool in I/R.

摘要

免疫检查点调节能够预防缺血再灌注(I/R)引起的过度组织损伤;因此,本研究旨在调查富含糖鞘脂微结构域1(PAG1)mRNA、miR-1206和小核仁RNA宿主基因14(SNHG14)在I/R期间的行为以及作为保护药物的己酮可可碱(PTX)的摄入情况。通过qRT-PCR测定PAG1/miR-1206/SNHG14的相对表达水平。采用ELISA技术测定心脏组织中细胞毒性T淋巴细胞相关抗原4(CTLA4)水平和PAG1蛋白表达。通过流式细胞术检测调节性T细胞。结果发现,SNHG14的相对表达在I/R中显著上调,但在PTX治疗组中受到抑制,同时miR-1206的相对表达水平增强。PAG1的基因和蛋白表达在有效剂量的PTX作用下下调。结果显示,(30和40mg/kg体重)PTX剂量显著抑制了CTLA4的发展。与I/R组相比,PTX保护组中调节性T细胞的平均值在(p<0.001)时显著降低。Spearman相关性分析显示,在I/R心脏组织中,SNHG14与miR-1206之间存在显著负相关,但SNHG14与PAG1之间存在显著正相关。结果表明,miR-1206和SNHG14可作为具有完美敏感性和特异性的生物标志物。使用PTX可减少心脏组织损伤。SNHG14和miR-1206可作为I/R的诊断工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1449/7846894/eacf3bd2161b/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1449/7846894/346a6148e845/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1449/7846894/d2da3efb28f6/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1449/7846894/55b87971e9a1/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1449/7846894/b0b845213ff3/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1449/7846894/eacf3bd2161b/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1449/7846894/346a6148e845/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1449/7846894/d2da3efb28f6/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1449/7846894/55b87971e9a1/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1449/7846894/b0b845213ff3/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1449/7846894/eacf3bd2161b/gr4.jpg

相似文献

1
Influence of pentoxifylline on gene expression of PAG1/ miR-1206/ SNHG14 in ischemic heart disease.己酮可可碱对缺血性心脏病中PAG1/miR-1206/SNHG14基因表达的影响
Biochem Biophys Rep. 2021 Jan 27;25:100911. doi: 10.1016/j.bbrep.2021.100911. eCollection 2021 Mar.
2
LncRNA SNHG14 promotes OGD/R-induced neuron injury by inducing excessive mitophagy via miR-182-5p/BINP3 axis in HT22 mouse hippocampal neuronal cells.长链非编码 RNA SNHG14 通过 miR-182-5p/BINP3 轴诱导过量的线粒体自噬促进 OGD/R 诱导的神经元损伤在 HT22 小鼠海马神经元细胞中。
Biol Res. 2020 Sep 10;53(1):38. doi: 10.1186/s40659-020-00304-4.
3
SNHG14 silencing suppresses the progression and promotes cisplatin sensitivity in non-small cell lung cancer.SNHG14 沉默抑制非小细胞肺癌的进展并增强顺铂敏感性。
Biomed Pharmacother. 2019 Sep;117:109164. doi: 10.1016/j.biopha.2019.109164. Epub 2019 Jun 26.
4
[Screening of phosphoprotein associated with glycosphingolipid microdomains 1 (PAG1) by cDNA microarray and influence of overexpression of PAG1 on biologic behavior of human metastatic prostatic cancer cell line in vitro].[应用cDNA芯片筛选糖鞘脂微结构域相关磷蛋白1(PAG1)及PAG1过表达对人转移性前列腺癌细胞系体外生物学行为的影响]
Zhonghua Bing Li Xue Za Zhi. 2010 Feb;39(2):88-94.
5
LncRNA SNHG14 potentiates pancreatic cancer progression via modulation of annexin A2 expression by acting as a competing endogenous RNA for miR-613.长链非编码 RNA SNHG14 通过作为 miR-613 的竞争性内源性 RNA 调节膜联蛋白 A2 的表达促进胰腺癌进展。
J Cell Mol Med. 2019 Nov;23(11):7222-7232. doi: 10.1111/jcmm.14467. Epub 2019 Sep 12.
6
The long non-coding RNA SNHG14 inhibits cell proliferation and invasion and promotes apoptosis by sponging miR-92a-3p in glioma.长链非编码RNA SNHG14通过在胶质瘤中吸附miR-92a-3p抑制细胞增殖和侵袭并促进细胞凋亡。
Oncotarget. 2018 Jan 4;9(15):12112-12124. doi: 10.18632/oncotarget.23960. eCollection 2018 Feb 23.
7
Long noncoding RNA SNHG14 accelerates cell proliferation, migration, invasion and suppresses apoptosis in colorectal cancer cells by targeting miR-944/KRAS axis through PI3K/AKT pathway.长链非编码 RNA SNHG14 通过 PI3K/AKT 通路靶向 miR-944/KRAS 轴促进结直肠癌细胞增殖、迁移、侵袭并抑制凋亡。
Eur Rev Med Pharmacol Sci. 2019 Nov;23(22):9871-9881. doi: 10.26355/eurrev_201911_19551.
8
LncRNA SNHG14/miR-5590-3p/ZEB1 positive feedback loop promoted diffuse large B cell lymphoma progression and immune evasion through regulating PD-1/PD-L1 checkpoint.LncRNA SNHG14/miR-5590-3p/ZEB1 正反馈环路通过调节 PD-1/PD-L1 检查点促进弥漫性大 B 细胞淋巴瘤的进展和免疫逃逸。
Cell Death Dis. 2019 Sep 30;10(10):731. doi: 10.1038/s41419-019-1886-5.
9
Long non-coding RNA SNHG14 promotes microglia activation by regulating miR-145-5p/PLA2G4A in cerebral infarction.长链非编码RNA SNHG14通过调控脑梗死中的miR-145-5p/PLA2G4A促进小胶质细胞活化。
Neuroscience. 2017 Apr 21;348:98-106. doi: 10.1016/j.neuroscience.2017.02.002. Epub 2017 Feb 16.
10
SNHG14 promotes the tumorigenesis and metastasis of colorectal cancer through miR-32-5p/SKIL axis.SNHG14 通过 miR-32-5p/SKIL 轴促进结直肠癌细胞的发生和转移。
In Vitro Cell Dev Biol Anim. 2019 Dec;55(10):812-820. doi: 10.1007/s11626-019-00398-5. Epub 2019 Aug 30.

引用本文的文献

1
Unlocking the life code: a review of SnoRNA functional diversity and disease relevance.解锁生命密码:小核仁RNA功能多样性及与疾病相关性综述
Cell Commun Signal. 2025 Jun 4;23(1):266. doi: 10.1186/s12964-025-02274-0.
2
Role of the circular RNA regulatory network in the pathogenesis of biliary atresia.环状RNA调控网络在胆道闭锁发病机制中的作用
Exp Ther Med. 2024 Jan 9;27(3):95. doi: 10.3892/etm.2024.12383. eCollection 2024 Mar.
3
Circ_0043256 upregulates KLF2 expression by absorbing miR-1206 to suppress the tumorigenesis of lung cancer.

本文引用的文献

1
MicroRNAs or Long Noncoding RNAs in Diagnosis and Prognosis of Coronary Artery Disease.微小RNA或长链非编码RNA在冠状动脉疾病诊断和预后中的作用
Aging Dis. 2019 Apr 1;10(2):353-366. doi: 10.14336/AD.2018.0617. eCollection 2019 Apr.
2
SNHG14 enhances gemcitabine resistance by sponging miR-101 to stimulate cell autophagy in pancreatic cancer.SNHG14 通过海绵吸附 miR-101 来增强吉西他滨耐药性,从而刺激胰腺癌中的细胞自噬。
Biochem Biophys Res Commun. 2019 Mar 19;510(4):508-514. doi: 10.1016/j.bbrc.2019.01.109. Epub 2019 Feb 5.
3
PVT1 regulates inflammation and cardiac function via the MAPK/NF-κB pathway in a sepsis model.
环状 RNA 0043256 通过吸附 miR-1206 上调 KLF2 表达,抑制肺癌的发生。
Thorac Cancer. 2023 Mar;14(7):683-699. doi: 10.1111/1759-7714.14794. Epub 2023 Jan 21.
4
Combination Approaches to Target PD-1 Signaling in Cancer.癌症中靶向 PD-1 信号的联合治疗方法。
Front Immunol. 2022 Jul 14;13:927265. doi: 10.3389/fimmu.2022.927265. eCollection 2022.
在脓毒症模型中,PVT1通过丝裂原活化蛋白激酶/核因子κB通路调节炎症反应和心脏功能。
Exp Ther Med. 2018 Dec;16(6):4471-4478. doi: 10.3892/etm.2018.6814. Epub 2018 Oct 1.
4
Long non-coding RNA SNHG14 promotes microglia activation by regulating miR-145-5p/PLA2G4A in cerebral infarction.长链非编码RNA SNHG14通过调控脑梗死中的miR-145-5p/PLA2G4A促进小胶质细胞活化。
Neuroscience. 2017 Apr 21;348:98-106. doi: 10.1016/j.neuroscience.2017.02.002. Epub 2017 Feb 16.
5
Role of the long non-coding RNA PVT1 in the dysregulation of the ceRNA-ceRNA network in human breast cancer.长链非编码RNA PVT1在人类乳腺癌ceRNA-ceRNA网络失调中的作用
PLoS One. 2017 Feb 10;12(2):e0171661. doi: 10.1371/journal.pone.0171661. eCollection 2017.
6
2,3,5,4'-Tetrahydroxystilbene-2-O-β-D-glucoside protects murine hearts against ischemia/reperfusion injury by activating Notch1/Hes1 signaling and attenuating endoplasmic reticulum stress.2,3,5,4'-四羟基二苯乙烯-2-O-β-D-葡萄糖苷通过激活Notch1/Hes1信号通路和减轻内质网应激来保护小鼠心脏免受缺血/再灌注损伤。
Acta Pharmacol Sin. 2017 Mar;38(3):317-330. doi: 10.1038/aps.2016.144. Epub 2017 Jan 23.
7
Vorapaxar: The Current Role and Future Directions of a Novel Protease-Activated Receptor Antagonist for Risk Reduction in Atherosclerotic Disease.沃拉帕沙:一种新型蛋白酶激活受体拮抗剂在降低动脉粥样硬化疾病风险中的当前作用及未来方向
Drugs R D. 2017 Mar;17(1):65-72. doi: 10.1007/s40268-016-0158-4.
8
Molecular Mechanisms for cAMP-Mediated Immunoregulation in T cells - Role of Anchored Protein Kinase A Signaling Units.T细胞中cAMP介导的免疫调节的分子机制——锚定蛋白激酶A信号单元的作用
Front Immunol. 2016 Jun 8;7:222. doi: 10.3389/fimmu.2016.00222. eCollection 2016.
9
Regulatory T Cells: Molecular Actions on Effector Cells in Immune Regulation.调节性T细胞:免疫调节中对效应细胞的分子作用
J Immunol Res. 2016;2016:1720827. doi: 10.1155/2016/1720827. Epub 2016 May 19.
10
The cAMP Pathway as Therapeutic Target in Autoimmune and Inflammatory Diseases.环磷酸腺苷(cAMP)信号通路作为自身免疫性疾病和炎症性疾病的治疗靶点
Front Immunol. 2016 Mar 31;7:123. doi: 10.3389/fimmu.2016.00123. eCollection 2016.